New vaccine platform promotes rare protective B cells
February 05, 2026
February 05, 2026
CAMBRIDGE, Massachusetts, Feb. 5 -- The Massachusetts Institute of Technology posted the following news:
* * *
New vaccine platform promotes rare protective B cells
*
A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as HIV and influenza. Of particular interest are antibodies that are "broadly neutralizing," meaning they can in principle eliminate multiple . . .
* * *
New vaccine platform promotes rare protective B cells
*
A longstanding goal of immunotherapies and vaccine research is to induce antibodies in humans that neutralize deadly viruses such as HIV and influenza. Of particular interest are antibodies that are "broadly neutralizing," meaning they can in principle eliminate multiple . . .